multiple myeloma

  • un.多发性骨髓瘤
  • 网络多发性骨髓癌;多发性骨瘤;则以多发性骨髓瘤

multiple myelomamultiple myeloma

multiple myeloma

多发性骨髓瘤

多发性骨髓瘤multiple myeloma)是浆细胞的恶性肿瘤。骨髓内肿瘤性浆细胞增生,常侵犯多处骨组织,引起多发性溶骨性病 …

多发性骨髓癌

6.多发性骨髓癌Multiple Myeloma):50岁以下的病人,较适合进行骨髓移植。基本上,多发性骨髓癌是一种绝症。

多发性骨瘤

...ma) ● 脑瘤(Brain Tumors) ● 多发性骨瘤Multiple Myeloma) ● 实体性肿瘤(Solid Tumor) ● Ewing 氏肉瘤(Ewing S…

则以多发性骨髓瘤

青少年的骨癌以原发性骨肉癌(Osteosarcoma)为主;而四十五岁以上的年龄层,则以多发性骨髓瘤Multiple myeloma)及 …

之多发性骨髓瘤

治疗正在接受肿瘤治疗之多发性骨髓瘤 (multiple myeloma)、低度非何杰金氏淋巴瘤 (low grade non-Hodgkin's lymphoma) 或慢 …

多发骨髓瘤

...ukemias)、淋巴瘤(lymphomas)以及多发骨髓瘤(multiple myeloma)等。

1
It found a small but inordinate number of multiple myeloma cases among responders under age 45. 那个案例中发现很小,但不正常数量的多发性肿瘤存在于45岁以下人员中。
2
We report a case of Citrobacter diversus-induced cellulitis, resembling streptococcal infection, in a patient with multiple myeloma. 我们报告柠檬酸转特殊情况引起的蜂窝组织炎,类似链球菌感染,在治疗多发性骨髓瘤患者。
3
The combination of thalidomide and dexamethasone is an effective induction therapy regimen for previously untreated multiple myeloma. 沙利度胺联合地塞米松是初发骨髓瘤一个有效的治疗方案。
4
Multiple myeloma (MM) is an incurable clonal B-cell malignancy with terminally differentiated plasma cells. 多发性骨髓病(MM)是一种浆细胞异常增生的难治愈的B细胞恶性肿瘤。
5
When Chen was a freshman her father was diagnosed with multiple myeloma, a fatal disease. 当陈晨还在读大一时,她的父亲被确诊为“多发性骨髓瘤”,生命垂危。
6
Although rare, multiple myeloma should be included in the differential diagnosis of osteosclerotic bone lesions. 因此,在遇骨硬化病灶时,仍应将较罕见的多发性骨髓瘤放入鑑别诊断。
7
To evaluate the efficacy of thalidomide and dexamethasone as induction therapy regimen in previously untreated multiple myeloma. 评估沙利度胺联合地塞米松在初发骨髓瘤诱导治疗中的疗效。
8
Of note, breast, prostate and lung cancer and multiple myeloma have a strong predilection for spreading to bone. 值得注意的是,乳腺癌,前列腺癌和肺癌,多发性骨髓瘤有强烈偏好的扩散到骨头。
9
To explore the effectivity and adverse reaction of thalidomide combined small-dose MP plan in treatment of senile multiple myeloma(MM). 探讨沙利度胺联合小剂量MP方案化疗治疗老年多发性骨髓瘤的临床疗效及不良反应。
10
The skull demonstrates the characteristic rounded " punched out" lesions of multiple myeloma. 颅骨显示多发性骨髓瘤典型的圆形“打孔样”病损。
11
A lot of reports suggested that bortezomib had a significant effect in treatment of multiple myeloma in out country. 国内有许多关于硼替佐米治疗多发性骨髓瘤临床疗效的研究报道指出其疗效显著。
12
Objective: To explore the diagnosis and differential diagnosis value of bone marrow biopsy for multiple myeloma ( MM ). 目的:探讨骨髓活检在多发性骨髓瘤(MM)诊断与鉴别诊断中的价值。
13
Stratification of patients with multiple myeloma (MM) may be important. 分层例多发性骨髓瘤(MM)可能是重要的。
14
In a test of 66 patients with the blood disease multiple myeloma, a full 100 percent of the subjects saw their cancer reduced by half. 66名患有多发性骨髓瘤(一种血液系统疾病)的患者参与了此项药物试验,结果所有患者的癌灶都缩减了一半。
15
The cancers treated include non small cell lung cancer, CML, AML, non-Hodgkin s lymphoma and multiple myeloma. 被治疗的癌症包括非小细胞肺癌、CML、AML、非何杰金(氏)淋巴瘤和多发性骨髓瘤。
16
Objective: To explore the value of bone marrow biopsy and bone marrow smear in multiple myeloma(MM) for diagnosis and treatment. 前言:目的:探讨骨髓活检与骨髓涂片在多发性骨髓瘤(MM)诊断中的价值。
17
In multiple myeloma(MM) pathogenesis, IL-6 has been identified as an essential growth and survival factor. 在多发性骨髓瘤(MM)的发病机制中,白细胞介素-6(IL-6)是肿瘤细胞生长和生存的一个重要因素。
18
With conventional therapy, only 5% of multiple myeloma patients achieve complete response. 常规治疗,只有5%的多发性骨髓瘤患者达到完全缓解。
19
Thalidomide: The drug thalidomide is used to treat multiple myeloma, and has helped some patients with CD. 沙立度胺:沙力度胺用于治疗多发性骨髓瘤,也帮助一些CD病人。
20
The history of brought bortezomib in clinical and used it for multiple myeloma treatment is about 5 years. 我国医疗界将硼替佐米应用于临床,用于治疗多发性骨髓瘤的历史大约5年。
21
OBJECTIVE: To investigate the VEGF effects on interleukin-6 secretion in multiple myeloma patients. 目的:观察血管内皮生长因子对多发性骨髓瘤患者骨髓基质细胞分泌白细胞介素6的影响。
22
Multiple myeloma is a blood cancer that typically strikes much later in life. 多发性肿瘤是一种血癌,通常在晚期才发作。
23
Objective To explore whether there is any association between multiple myeloma(MM)and the infection of Borna disease virus(BDV). 目的探讨Borna病病毒(BDV)感染与人类多发性骨髓瘤(MM)发病的关系。
24
Clinical analysis of nosocomial infections for 46 patients with multiple myeloma. 多发性骨髓瘤医院感染46例临床分析。
25
Multiple myeloma is a cancer of white blood cells that attacks and destroys bone and which more commonly afflicts people in their mid-60s. 多发性骨髓癌是一种白血细胞袭击和破坏骨骼的癌症,这个普遍困扰60多岁的人群。
26
Multiple myeloma is a cancer of blood plasma cells. 多发性骨髓瘤是一种血浆细胞癌症。
27
Method Analyze the clinical data of 6 multiple myeloma patients. 方法对6例使用雷那立度胺的多发性骨髓患者临床资料进行分析。
28
Cancergrams: CT13 Clinical Evaluation and Treatment of Multiple Myeloma and Other Gammopathies. CT13多发性骨髓瘤和其他起因不明病临床评价和治疗。
29
To investigate the mechanism of interleukin 6 (IL-6) overexpression in multiple myeloma. 目的:探讨白细胞介素6(IL-6)在多发性骨髓瘤中过度表达的机制。
30
Multiple myeloma is a kind of malignant hyperplastic diseases, which is origined from B cell line and can produce monoclonal immunoglobulin. 多发性骨髓瘤是一种起源于B细胞系并能够产生单克隆免疫球蛋白的恶性增生性疾病。